Neuropeptides and electroconvulsive treatment

Journal of ECT

Volumn 15, Issue 1, 1999, Pages 60-75

  Mathé, Aleksander A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Depression; Electroconvulsive therapy; Neurokinin A; Neuropeptide Y; Neuropeptides; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN RELEASING FACTOR; DIZOCILPINE; GALANIN; KAINIC ACID; LITHIUM; MONOAMINE; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; PENTETRAZOLE; PSYCHEDELIC AGENT; SOMATOSTATIN; SUBSTANCE P; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; GRAND MAL SEIZURE; HIPPOCAMPUS; NONHUMAN; OCCIPITAL CORTEX; PEPTIDE SYNTHESIS; RAT; SCHIZOPHRENIA;

ANIMALS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SCHIZOPHRENIA; SEIZURES;

EID: 0032982595     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (123)

1. Aulakh CS, Hill JL, Murphy DL. A comparison of feeding and response to serotonin agonists in three rat strains. Pharmacol Biochem Behav 1989;31:567-71.
2. Aulakh, CS, Tolliver T, Wozniak KM, Hill JL, Murphy DL. Functional and biochemical evidence for altered serotonergic function in the Fawn-Hooded rat strain. Pharmacol Biochem Behav 1994;49:615-20.
3. Arató MA, Apéria B, Béla A, Mathé AA. Prolactin (PRL), prostaglandin E (PGE) and cortisol (CS) responses to electroconvulsive treatment (ECT) in schizophrenia and depression. New Research, Proc Ann Meet APA, 1993.
4. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997;17:8927-36.
5. Bazan NG, Birkle DL, Sanjeeva Reedy T. Arachidonic acid release from phosphoinositide cycle after electroconvulsive shock. Proc 6th Int Conf Prostaglandins Related Compounds, p. 140, 1986.
6. Bellmann R, Sperk G. Effects of antidepressant drug treatment on levels of NPY or prepro-NPY-mRNA in the rat brain. Neurochem Int 1993;22:183-7.
7. Berrettini WH, Doran AR, Kelsoe J, Roy A, Pickar D. Cerebrospinal fluid neuropeptide Y in Depression and Schizopohrenia. Neuropsychopharmacology 1987;1:81-3.
8. Bissette G, Widerlöv E, Walléus H, Karlsson I, Eklund K, Forsman A, Nemeroff CB. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatrie disorders. Arch Gen Psychiatry 1986;43:1148-51.
9. Bissette G, Nemeroff CB. The Neurobiology of Neurotensin. Psychopharmacology: In: Psychopharmacology: The Fourth Generation of Progress, Bloom FE, Kupfer DJ (Eds). New York: Raven Press, pp. 573-83, 1995.
10. Cerletti U, Bini L. Un' nuovo metodo di shockterapie "L'élettro-shock." Boll Acad Med Roma 1938;64:136-8.
11. Cheng J-T, Chang C-L, Tsai C-L. Inhibitory effect of neuropeptide Y (NPY) on the in vitro activity of tyrosine hydroxylase. Neurosci Lett 1994;167:117-20.
12. Cheng J-T, Chang C-L, Tsai C-L. Inhibitory effect of neuropeptide Y (NPY) on the in vitro activity of dopamine-β-hydroxylase. Neurosci. Lett 1992;136:36-8.
13. DeSauza EB, Grigoriadis DE. Corticotropin-releasing factor. Physiology, Pharmacology, and Role in Central Nervous System and Disorders. In: Psychopharmacology: The Fourth Generation of Progress, Bloom FE, Kupfer DJ (Eds). New York: Raven Press, pp. 505-517, 1995.
14. Drumheller A, Bouali SM, Fournier A, St-Pierre S, Jolicoeur FB. Neurochemical effects of neuropeptide Y (NPY) and NPY2-36. Neuropeptides 1994;27:291-6.
15. Deutch AY, Roth RH. Calcitonin gene-related pcptide in the ventral tegmental area: selective modulation of profrontal cortical dopamine metabolism. Neurosci Lett 1987;74:169-74.
16. Deutch AY, Zahm DS. The current status of neurotensin-dopamine interactions. Issues and speculations. Ann NY Acad Science 1992;668:232-52.
17. Devanand DP, Sackem HA. Electroconvulsive therapy: efficacy, side effects and mechanisms of action. In: Pohl R, Gershon S (Eds). The Biological Basis of Psychiatric Treatment, vol 3. Progress in Basic Clinical Pharmacology. Basel: Karger, pp 170-210, 1990.
18. Duman RS, Heningcr GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
19. Engber TM, Boldry RC, Kuo S, Chase TN. Dopaminergic modulation of striatal neuropepides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res 1992;581:261-72.
20. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381:415-18.
21. Forstermann U, Heldt R, Knappen F, Hertting G. Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res 1982;240:303-10.
22. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain: the disposition of (3H) norepinephrine, (3H) dopamine and (3H) dopa in various regions of the brain. J Neurochem 1965;13:655-69.
23. Gottfries C-G, Frederiksen S, Heilig M. Neuropeptides and Alzheimer's disease. Eur Neuropsychopharmacol 1995;5:491-500.
24. 2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 1994;113:45-67.
25. Gruber S, Haij K, Mathé AA. Novel action of psychotomimetic drugs: amphetamine, phencyclidine and MK-801 affect neuropeptides in brain. Psychopharmacol 1995;118:B9.
26. Gruber S, Mathé AA. Both antipsychotic drugs and psychotomimetic compounds affect peptides in brain. Nordic J Psychiatry 1996a;50:106.
27. Gruber S, Nomikos GG, Svensson TH, Mathé AA. Effects of D-amphetamine and doparnine receptor antagonists on calcitonin gene-related peptide levels in ventral striatum. In: Monitoring Molecules in Neuroscience. Proc. 7th Int. Conf. on in vivo Methods. González-Mora JE, Borges R, Mas M (Eds), p. 205-206, 1996b.
28. Heilig M, Wahlestedt C, Ekman R, Widerlöv E. Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur J Pharmacol 1988;147:465-7.
29. 13-36 on the brain monoaminergic systems of the rat. J Neural Transm 1990;79:193-208.
30. Heilig M, Widerlöv E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol 1995;9:115-36.
31. Heilig M, Ekman R. Chronic parenteral antidepressant treatment in rats: Unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochem Int 1995;26:351-5.
32. Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: A modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiat 1996;29:2-11.
33. Hertel P, Mathé JM, Nomikos GG, Iurlo M, Mathé AA, Svensson TH. Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Beh Brain Res 1996;72:103-14.
34. Hoffmann O, Johnson L, Mebius C, Stenfors C, Vinnars E, Mathé AA. Isoflurane and electroconvulsive treatment in depression: a pilot study. In: Stefanis CN, Rabavilas AD, Soldatos CR (Eds). Pharmacotherapies, Psychotherapies, Other Therapies, vol. 3. Amsterdam: Elsevier, pp. 480-6, 1990.
35. Jiménez P, Mathé AA. Brain neuropeptides in animal models of depression. Effects of electroconvulsive treatments. Nordic J Psychiatry 1996a;50:92.
36. Jiménez P, Overstreet DH, Mathé AA. Neuropeptide Y differences between female and male rat brain: lower baseline and decreased response to electroconvulsive treatment in females. Biological and clinical implications. 26th Ann Meet. Proc. Society Neuroscience, Washington DC 1996b;22:1553.
37. Jiménez PA, Darenberg J, Overstreet D, Mathé AA. Are male and female brains different? Analysis of neuropeptides and monoamines in rat brain regions. Biol Psychiatry 1997;42:235S.
38. Jousisto-Hanson J, Stenfors C, Theodorsson E, Mathé AA. Effect of lithium on rat brain neurotensin, corticotropin releasing factor, somatostatin and vasoactive intestinal peptide. Lithium 1994;5:83-90.
39. Kakigi T, Maeda K. Effect of serotonergic agents on regional concentrations of somatostatin- and neuropeptide Y-like immunoreactivities in rat brain. Brain Res 1992;599:45-50.
40. Kakigi T, Maeda K, Kaneda H. Repeated administration of antidepressant drugs reduces regional somatostatin concentrations in rat brain. J Affect Disord 1992;25:215-20.
41. Kasckow J, Nemeroff CB. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions. Regul Pept 1991;36:153-64.
42. Kellar KJ. Effects of electroconvulsive shock on noradrenergic and serotonergic receptors in rat brain. Pharmacopsychiat 1987;20:30-4.
43. Kimura S, Ogawa T, Goto K, Sugita Y, Munekata E, Kanazawa I. Endogenous ligands for tachykinin receptors in mammals. In: Jordan CC, Oehme P (Eds). Substance P, Metabolism and Biological Actions. London/Philadelphia: Taylor and Francis, pp 33-43, 1985.
44. Klapstein GJ, Colmers WF. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 1993;3:103-12.
45. Kling MA, Geracioti TD, Licinio J, Michelson D, Oldfield EH, Gold PW. Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings. Psychopharmacol Bull 1994;30:489-94.
46. Kovács A, Papp E, Telegdy G. In vivo microdialysis study of effects of calcitonin gene-related peptide (CGRP) on rat striatal dopamine release. In: Louilot A, Durkin T, Spampinato U, Cador M. (Eds). Proc 6th Int Conf on In Vivo Methods. Seignosse, France: Les Tuquets, pp 137-38, 1994.
47. Kronfol Z, Hamdan-Allen G, Goel K, Hill EM. Effects of single and repeated electroconvulsive therapy sessions on plasma ACTH, prolactin, growth hormone and cortisol concentrations. Psychoneuroendocrinology 1991;16:345-52.
48. Langer G, Neurmark J, Koinig G, Graf M, Schönbeck G. Rapid psychotherapeutic effects of anesthesia with isoflurane (ES narcotherapy) in treatment-refractory depressed patients. Neuropsychobiology 1985; 14:118-20.
49. Langer G, Koining G, Neumark J. "Narcotherapy" with isoflurane anethesias: psychothrapeutic profile, flat-line in EEG and other observations. Clin. Neuropharmacol 1986;9:450-2.
50. Langer G, Karazman R, Neumark J, Saletu B, Schönbeck G, Grünberger J, et al. Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. Pharmacopsychiatry 1995;31:182-94.
51. Marksteiner J, Lassmann H, Saria A, Humpel C, Meyer DK, Sperk G. Neuropeptide levels after pentylenetetrazol kindling in the rat. Eur J Neumsci 1990;2:98-103.
52. Marksteiner J, Sperk G. Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decrease seizure threshold. Neuroscience 1988;26:379-85.
53. 2 type. Eur J Pharmacy 1994;230:231-4.
54. Martling C-R, Theodorsson-Norheim E, Lundberg JM. Occurence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci 1987;40:1633-43.
55. Mathé AA, Koinig G, Apéria B, Aschauer H, Bergman P, Graf M, et al. Effects of biological treatments in psychiatry on prostaglandin metabolites in plasma. Proc. 6th Int. Conference on Prostaglandins and Related Compounds, Florence, Italy. New York: Raven Press, p. 122, 1986.
56. 2 metabolite in major depressive disorder. Prog Neuro-psychopharmacol Biol Psychiat 1987;11:701-7.
57. Mathé AA, Stenfors C, Brodin E, Theodorsson E. Neuropeptides in Brain: Effects of Microwave Irradiation and Decapitation. Life Sci 1990a;46:287-93.
58. Mathé AA, Jousisto-Hanson J, Stenfors C, Theodorsson E. Effect of Lithium on Tachykinins, Calcitonin Gene-Related peptide, and Neuropeptide Y in Rat Brain. J Neurosci Res 1990b;26:233-7.
59. Mathé AA, Ågren H, Srinivasan GR, Theodorsson E, Van Kammen DP. Calcitonin gene-related peptide (CGRP), endothelin (ET) and neuropeptide Y (NPY) in cerebrospinal fluid (CSF) of patients with schizophrenia and major depression. Psychopharmacology 1993;111:B3.
60. Mathé AA, Hertel P, Nomikos GG, Mathé JM, Svensson TH. Microdialysis of extracellular neurotensin and calcintonin gene-related peptide from the rat brain: effects of d-amphetamine and phencyclidine. In: Monitoring Molecules in Neuroscience. Proc. 6th Int. Conf. on in vivo Methods. Louilot A, Durkin T, Spampinato U, Cador M, eds. Seignosse, France: Les Tuquets, pp 361-2, 1994a.
61. Mathé AA, Norstedt Wikner B, Stenfors C, Theodorsson E. Effects of lithium on neuropeptide Y, neurokinin A and substance P in brain and peripheral tissues of rat. Lithium 1994b;5:241-7.
62. Mathé AA, Nomikos GG, Svensson TH. Effects of acute and chronic electroconvulsive treatment on interstitial concentrations of somatostatin in the rat hippocampus and striatum. Prog Neuro-Psychopharmac Biol Psych 1995;19:323-32.
63. Mathé AA, Nomikos GG, Gruber S, Hertel P, Mathé JM, Svensson TH. The psychotomimetic drugs d-ampethamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat. J Neurosci Res 1996a;46:316-23.
64. Mathé AA, Rudorfer MV, Stenfors C, Manji HK, Potter WC, Theodorsson E. Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin and neurokinin A concentrations in cerebrospinal fluid of depressed patients. Depression 1996b;3:250-6.
65. Mathé AA, Gruber S, Jimenez P, Theodorsson E, Stenfors C. Effects of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A and calcitonin gene-related peptide in rat brain. Neurochem Res 1997;22:629-36.
66. Mathé AA, Jimenez P, Theodorsson E, Stenfors C. Neuropeptide Y, neurokinin A and rieurotensin in brain regions of Fawn Hooded "depressed," Wistar and Sprague Dawley rats. Effects of electroconvulsive stimuli. Prog Neuro-Psychopharmacol Biol Psychiat 1998;22:529-46.
67. Maynard KI, Burnstock G. Evoked noradrenaline release in the rabbit ear artery: enhancement by purines, attenuation by neuropeptide Y and lack of effect of calcitonin gene-related peptide. Br J Pharmacol 1994;112:123-6.
68. Meduna LJ. Versuche über die biologische Beeinflussung des Abaufes der Schizophrenia: Camphor und Cardiazolkrampfe [German]. Z Ges Neurol Psychiatr 1935;152:235-62.
69. Midgley LP, Bush LG, Gibb JW, Hanson GR. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen. Brain Res 1992;593:89-96.
70. Midgley LP, Bush LG, Gibb JW, Hanson GR. Differential regulation of neuropeptide Y systems in limbic structures in the rat. J Pharmacy Exp Ther 1993;267:707-13.
71. Mikkelsen JD, Woldbye DPD, Kragh J, Larsen PJ, Bolwig TG. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyms. Mol Brain Res 1994; 23:317-22.
72. Nemeroff CB, Bissette G, Akil H, Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, β-endorphin and somatostatin. Br J Psychiatry 1991;158:59-63.
73. Nilsson L. Somatostatin Neurotransmission. Studies on experimentally induced cognitive changes and Alzheimer's disease. Ph.D. Thesis, Karolinska Institute, Stockholm, 1996.
74. Ordway GA, Stockmeier CA, Meltzer HY, Ocerholser JC, Jaconetta S, Widdowson PS. Neuropeptide Y in frontal cortex is not altered in major depression. J Neurochem 1995;65:1646-50.
75. Orzi F, Zoli M, Passarelli F, Ferraguti F, Fieschi C, Agnati LF. Repeated electroconvulsive shock increases fibrillary acidic protein, ornithine decarboxylase, somatostatin and cholecystokinin immunoreactivities in the hippocampal formation of the rat. Brain Res 1990;533:223-31.
76. Overstreet DH. The flinders sensitive line rats. A genetic animal model of depression. Neurosci Biobehav Rev 1993;17:51-68.
77. Overstreet DH, Rezvani A, Janowsky DS. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol Psychiatry 1992;31:919-36.
78. Passarelli F, Orzi F. Somatostatin mRNA in the hippocampal formation following electroconvulsive shock in the rat. Neurosci Lett 1993;153:197-201.
79. Pavia JM, Hastings JA, Morris MJ. Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo. Brain Res 1995;690:108-11.
80. Radke JM, MacLennan AJ, Vincent SR, Fibiger HC. Comparison between short- and long-term haloperidol administration on somatostatin and substance P concentrations in the rat brain. Brain Res 1988;445:55-60.
81. Radke JM, MacLennan AJ, Beinfeld MC, Bissette G, Nemeroff CB, Vicent SR, Fibiger HC. Effects of short- and long-term haloperidol administration and neurotensin concentrations in the rat. Brain Res 1989;480:178-83.
82. Rizzi M, Monno A, Samanin R, Sperk G, Vezzani A. Electrical kindling of the hippccampus is associated with functional activation of neuropeptide Y-containing neurons. Eur J Neurosci 1993;5:1534-38.
83. Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R, Bolilnger J, Reichlin S. CSF somatostatin in affective illness. Arch Gen Psychiatry 1983;40:409-12.
84. Rubinow DR, Post RM, Gold PW, Ballenger JC, Reichlin S. Effects of carbamazepine on cerebrospinal fluid somatostatin. Psychopharmacology 1985;85:210-13.
85. Rubinow DR, Davis CL, Post RM. Somatostatin in the Central Nervous System. In: Psychopharmacology: The Fourth Generation of Progress. Bloom FE, Kupfer DJ (Eds), New York: Raven Press, pp. 553-62, 1995.
86. Rudorfer MV, Risby ED, Osman OT, Gold PW, Potter WZ. Hypothalamic - pituitary - adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapy. Biol Psychiatry 1991;29:253-64.
87. Röder C, Schwarzer C, Vezzani A, Gobbi M, Mennini T, Sperk G. Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neurosci 1996;70:47-55.
88. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987;144:1449-55.
89. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy, In: The Psychiatric Clinics of North America: Electroconvulsive Therapy, vol. 14. Kellner CH (Ed). New York: W. B. Saunders, Harcourt Brace Jovanovich, pp 803-43, 1991.
90. Sakai K, Maeda K, Chihara K, Kaneda H. Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats. Neuropeptides 1995;29:157-61.
91. Smialowska M, Legutko B. Influence of imipramine on neuropeptide Y immunoreactivity in the rat brain. Neurosci 1991;41:767-71.
92. Smialowska M, Legutko B. Haloperidol-induced increase in neuropeptide Y immunoreactivity in the locus coeruleus of the rat brain. Neuroscience 1992;47:351-5.
93. Smialowska M. An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons. Neuroscience 1995;66:589-95.
94. Smialowska M, Bijak M, Sopala M, Tokarski K.. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electophysiological study. Neuropeptides 1996;30:7-12.
95. Soghomonian J-J, Chesselet M-F. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenter RNA levels in the striatum, the entopenduncular nucleus and the lateral hypothalamus of the rat. Neuroscience 1991;42:49-59.
96. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurones induced by limbic seizures in the rat. Neuroscience 1992;50:831-46.
97. Stenfors C, Theodorsson E, Mathé AA. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J Neuroscience Research 1989;24:445-50.
98. Stenfors C, Theodorsson E, Mathé AA. Brain neuropeptides: changes by treatment with the convulsants pentylenetetrazole and bicuculline. Prog Neuro-Psychopharmacol Biol Psych 1992a;16:747-53.
99. Stenfors C, Srinivasan GR, Theodorsson E, Mathé AA. Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin. Brain Res 1992b;596:251-8.
100. Stenfors C, Mathé AA. Theodorsson E. Repeated electroconvulsive stimuli: changes in neuropeptide Y, neurotensin and tachykinin concentrations in time. Prog Neuro-Psychopharmacol Biol Psychiat 1994;18:201-9.
101. Stenfors C, Bjellerup P, Mathé AA, Theodorsson E. Concurrent analysis of neuropeptides and biogenic amines in brain tissue of rats treated with electroconvulsive stimuli. Brain Res 1995a;698:39-45.
102. Stenfors C, Mathé AA, Theodorsson E. Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. J Neurosci Res 1995b;41:206-12.
103. Theodorsson-Norheim E, Norheim I, Öberg K, Brodin E, Lundberg JM, Tatemoto K. Neuropeptide K. A major tachykinin in plasma and tumor tissues from carcinoid patients. Biochem Biophys Res Comm 1985;131:77-83.
104. Theodorsson E, Stenfors C, Mathé AA. Microwave irradiation increases recovery of neuropeptides from brain tissues. Peptides 1990a;11:1191-7.
105. Theodorsson E, Mathé AA, and Stenfors C. Brain neuropeptides: tachykinins, neuropeptide Y, neurotensin and vasoactive intestinal polypeptide in the rat brain: modifications by ECT and indomethacin. Prog Neuropsychopharmacol Biol Psychiatry 1990b;14:387-407.
106. Tsuda K, Yokoo H, Goldstein M. Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices. Hypertension 1989;14:81-6.
107. Valejo M, Carter DA, Biswas S, Lightman SL. Neuropeptide Y alters monoamine turnover in the rat brain. Neurosci Lett 1987;73:155-160.
108. Wahlestedt C, Blendy JA, Kellar KJ, Heilig M, Widerlöv E, Ekman R. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res 1990;507:65-8.
109. Wahlestedt C, Karoum F, Jaskiw G, Wyatt JR, Larhammar D, Ekman R, Reis DJ. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc Natl Acad Sci 1991;88:2078-82.
110. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-YI receptors by antisense oligodeoxynucleotides. Science 1993;259:528-31.
111. Wahlestedt C, Heilig M. Neuropeptide Y and related peptides. In: Psychopharmacology. The Fourth Generation of Progress. Bloom FE, Kupfer DJ (Eds). New York: Raven Press, pp 543-51, 1995.
112. Wallenstein MC. Differential effect of prostaglandin synthetase inhibitor pretreatment on pentylenetetrazole-induced seizures in rat. Arch Int Pharmacodyn 1985;275:93-104.
113. Widdowson PS, Halaris AE. Increased levels of neuropeptide-Y immunoreactivity in rat brain limbic structures following antidepressant treatment. J. Neurochem 1989;52(suppl):577.
114. Widdowson PS, Ordway GA, Halaris AE. Reduced neuropeptide Y in suicide brain. J Neurochem 1992;59:73-80.
115. Widerlöv E, Lindström LH, Wahlestedt C, Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiat Res 1988;22:69-79.
116. Woldbye DPD, Madsen TM, Larsen PJ, Mikkelsen JD, Bolwig TG. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 1996;737:162-68.
117. Woldbye DPD, Larsen PJ, Mikkelsen JD, Klemp K, Madsen TM, Bolwig TG. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Medicine 1997;3:761-4.
118. Zachrisson O, Mathé AA, Stenfors C, Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Molec Brain Res 1995a;31:71-85.
119. Zachrisson O, Mathé AA, Stenfors C, Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neurosci Lett 1995b;194:89-92.
120. Zachrisson O, Mathé AA, Lindefors N. Effects of chronic lithium and clectroconvulsive stimuli on cholecystokinin mRNA expression in the rat brain. Mol Brain Res 1996;43:347-50.
121. 1 receptor mRNA in specific regions of the rat striatum after electroconvulsive stimuli. Eur J Pharmac 1997;319:191-5.
122. Zheng J, Zhang P, Hexum TD. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. J Pharmacol Exp Ther 1997;52:1027-33.
123. Zis AP, Nomikos GG, Damsma G, Fibiger HC. In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum. Psychopharmacology 1991;103:343-50.